Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T B Vree

Showing results (231-240 of 323) with videos related to

Pageof 33
Sort By:
Lancet (London, England)|August 17, 1991
Adverse reactions to co-trimoxazole in HIV infectionA J van der Ven, P P Koopmans, T B Vree, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1994
Drug intolerance in HIV diseaseA J van der Ven, P P Koopmans, T B Vree, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 11, 1992
[Frequent side effects of cotrimoxazole in persons infected with HIV, possibly due to metabolites of sulfamethoxazole]A J van der Ven, P P Koopmans, T B Vree, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1990
Pharmacokinetics, N1-glucuronidation, and N4-acetylation of sulfa-6-monomethoxine in humansT B Vree, E W Beneken Kolmer, Y A Hekster, et al.
International Journal of Clinical Pharmacology Research|January 1, 1989
Comparison of the pharmacokinetics of intravenously administered rac-baclofen and its (-)-(R)- and (+)-(S)-enantiomers in dogsE W Wuis, M J Dirks, E F Termond, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Adverse reactions to co-trimoxazole in HIV infection: a reappraisal of the glutathione-hydroxylamine hypothesisA J van der Ven, T B Vree, P P Koopmans, et al.
Biopharmaceutics & Drug Disposition|July 1, 1983
Pharmacokinetics, acetylation-deacetylation, renal clearance, and protein binding of sulphamerazine, N4-acetylsulphamerazine, and N4-trideuteroacetylsulphamerazine in 'fast' and 'slow' acetylatorsT B Vree, C A Hekster, M Baakman, et al.
The Veterinary Quarterly|October 1, 1986
Comparative pharmacokinetics, bioavailability and renal clearance of five parenteral oxytetracycline-20% formulations in dairy cowsD J Mevius, J F Nouws, H J Breukink, et al.
Obstetrics and Gynecology|February 1, 1993
Achievement of therapeutic concentrations of cefuroxime in early preterm gestations with premature rupture of the membranesJ W De Leeuw, F J Roumen, P X Bouckaert, et al.
Pharmaceutisch Weekblad. Scientific Edition|December 9, 1988
Clinical effects and pharmacokinetics of articainic acid in one volunteer after intravenous administrationG E Van Oss, T B Vree, A M Baars, et al.
Pageof 33

Showing results (231-240 of 323) with videos related to

Sort By:
Pageof 33
Lancet (London, England)|August 17, 1991
Adverse reactions to co-trimoxazole in HIV infectionA J van der Ven, P P Koopmans, T B Vree, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1994
Drug intolerance in HIV diseaseA J van der Ven, P P Koopmans, T B Vree, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 11, 1992
[Frequent side effects of cotrimoxazole in persons infected with HIV, possibly due to metabolites of sulfamethoxazole]A J van der Ven, P P Koopmans, T B Vree, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1990
Pharmacokinetics, N1-glucuronidation, and N4-acetylation of sulfa-6-monomethoxine in humansT B Vree, E W Beneken Kolmer, Y A Hekster, et al.
International Journal of Clinical Pharmacology Research|January 1, 1989
Comparison of the pharmacokinetics of intravenously administered rac-baclofen and its (-)-(R)- and (+)-(S)-enantiomers in dogsE W Wuis, M J Dirks, E F Termond, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Adverse reactions to co-trimoxazole in HIV infection: a reappraisal of the glutathione-hydroxylamine hypothesisA J van der Ven, T B Vree, P P Koopmans, et al.
Biopharmaceutics & Drug Disposition|July 1, 1983
Pharmacokinetics, acetylation-deacetylation, renal clearance, and protein binding of sulphamerazine, N4-acetylsulphamerazine, and N4-trideuteroacetylsulphamerazine in 'fast' and 'slow' acetylatorsT B Vree, C A Hekster, M Baakman, et al.
The Veterinary Quarterly|October 1, 1986
Comparative pharmacokinetics, bioavailability and renal clearance of five parenteral oxytetracycline-20% formulations in dairy cowsD J Mevius, J F Nouws, H J Breukink, et al.
Obstetrics and Gynecology|February 1, 1993
Achievement of therapeutic concentrations of cefuroxime in early preterm gestations with premature rupture of the membranesJ W De Leeuw, F J Roumen, P X Bouckaert, et al.
Pharmaceutisch Weekblad. Scientific Edition|December 9, 1988
Clinical effects and pharmacokinetics of articainic acid in one volunteer after intravenous administrationG E Van Oss, T B Vree, A M Baars, et al.
Pageof 33